<DOC>
	<DOCNO>NCT00572117</DOCNO>
	<brief_summary>The purpose study determine whether use topiramate effective treatment alcohol dependence ( i.e . decrease drink ) patient bipolar disorder .</brief_summary>
	<brief_title>Adjunctive Topiramate Treatment Alcohol Dependence Patients With Bipolar Disorder</brief_title>
	<detailed_description>Alcohol substance use disorder common bipolar disorder bipolar disorder DSM-IV ( Diagnostic Statistical Manual Mental Disorders ) Axis I disorder , estimate occur 60 % patient bipolar disorder . Alcohol use associate poor outcome bipolar disorder , yet co-occurring condition understudied . To date , one publish placebo-controlled trial agent treatment alcohol dependence alcohol dependence bipolar disorder . The purpose propose study evaluate efficacy topiramate treatment alcohol dependence patient bipolar disorder . This 12-week , randomize , placebo-controlled study efficacy topiramate adjunctive standard treatment bipolar disorder patient alcohol dependence bipolar disorder . Additional aim study document safety tolerability topiramate population , evaluate effect decrease drinking mood symptom . The study involve enrollment total 80 patient co-occurring alcohol dependence bipolar disorder course 40 month Massachusetts General Hospital ( MGH ) Bipolar Clinic Research Program ( BCRP ) ( www.manicdepressive.org ) . With conservative estimate 30 % dropout rate , approximately 56 80 patient two comorbid condition complete 12 week treatment either topiramate placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>1 . Age 18+ 2 . Written informed consent . 3 . Meet DSMIV criterion ( SCID ) alcohol dependence . 4 . Meet DSMIV criterion ( SCID ) bipolar disorder I II disorder . 5 . ≥ 8 heavy drinking day ( define ≥ 5 standard drink per day men , ≥ 4 standard drink per day woman ) prior 4 week . 6 . During baseline visit , patient must stable dose accepted maintenance treatment bipolar disorder past 4 week . If subject one agent , least one agent must adequately dose . 7 . Antidepressant treatment permit dose stable past 4 week . 1 . Pregnant woman woman child bear potential use medically accept mean contraception ( condom , diaphragm , spermicide , intrauterine device , tubal ligation , partner vasectomy ) . Because risk lower oral contraceptive blood level topiramate , woman whose sole mean contraception oral contraceptive hormonal implant ask use additional barrier method birth control treatment study drug . 2 . Women lactate . 3 . Age 18 . 4 . Patients ≥ 8 heavy drinking day 4 week prior baseline visit . 5 . Important alcohol withdrawal symptom ( Clinical Institute Withdrawal Assessment AlcoholRevised , CIWAAr , score &gt; 15 ) 6 . Urine toxicological screen positive amphetamine cocaine . 7 . Meets DSMIV criterion current substance dependence drug cannabis nicotine . 8 . Currently meet full DSMIV criterion manic , hypomanic , mixed episode . 9 . Serious suicide homicide risk , assess evaluate clinician . 10 . Unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurological , hematological disease uncontrolled seizure disorder . 11 . History nephrolithiasis , treatment drug associate nephrolithiasis . 12 . Current treatment zonisamide . 13 . Current treatment carbonic anhydrase inhibitor , include acetazolamide , dorzolamide , methazolamide . 14 . Current treatment drug know decrease drinking . 15 . Subjects begin new psychosocial treatment within 12 week study enrollment . Subjects receive psychosocial treatment stable least 12 week prior study entry , however , permit enroll study . 16 . Any psychotic disorder , include schizoaffective disorder ( current past ) . 17 . Clinical laboratory evidence untreated hypothyroidism . 18 . Patients diagnosis history glaucoma 19 . Patients require excluded medication ( see table detail ) . 20 . Psychotic feature current episode history psychotic disorder , assess SCID . 21 . Past intolerance topiramate . 22 . Any use topiramate past 12 month . 23 . Any investigational psychotropic drug within last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Manic Disorder</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol Abuse</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Evaluation Trial</keyword>
	<keyword>Intervention Trial</keyword>
	<keyword>Validation Studies</keyword>
</DOC>